Cite
Diagnostic performance of 18F-DCFPyL positron emission tomography/computed tomography for biochemically recurrent prostate cancer and change-of-management analysis.
MLA
Chaussé, Guillaume, et al. “Diagnostic Performance of 18F-DCFPyL Positron Emission Tomography/Computed Tomography for Biochemically Recurrent Prostate Cancer and Change-of-Management Analysis.” Canadian Urological Association Journal, vol. 15, no. 6, June 2021, pp. 173–78. EBSCOhost, https://doi.org/10.5489/cuaj.6817.
APA
Chaussé, G., Ben-Ezra, N., Stoopler, M., Levett, J. Y., Niazi, T., Anidjar, M., Abikhzer, G., & Probst, S. (2021). Diagnostic performance of 18F-DCFPyL positron emission tomography/computed tomography for biochemically recurrent prostate cancer and change-of-management analysis. Canadian Urological Association Journal, 15(6), 173–178. https://doi.org/10.5489/cuaj.6817
Chicago
Chaussé, Guillaume, Noah Ben-Ezra, Michelle Stoopler, Jeremy Y. Levett, Tamim Niazi, Maurice Anidjar, Gad Abikhzer, and Stephan Probst. 2021. “Diagnostic Performance of 18F-DCFPyL Positron Emission Tomography/Computed Tomography for Biochemically Recurrent Prostate Cancer and Change-of-Management Analysis.” Canadian Urological Association Journal 15 (6): 173–78. doi:10.5489/cuaj.6817.